OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SIRT4 and SIRT6 Serve as Novel Prognostic Biomarkers With Competitive Functions in Serous Ovarian Cancer
Huihuan Wang, Juan Li, Rui Huang, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 8

Showing 8 citing articles:

Sirtuins, a key regulator of ageing and age-related neurodegenerative diseases
Vidhi Bhatt, Anand Krishna Tiwari
International Journal of Neuroscience (2022) Vol. 133, Iss. 10, pp. 1167-1192
Closed Access | Times Cited: 13

Cisplatin-induced PANDAR-Chemo-EVs contribute to a more aggressive and chemoresistant ovarian cancer phenotype through the SRSF9-SIRT4/SIRT6 axis
Hao Wang, Yinuo Li, Yanan Wang, et al.
Journal of Gynecologic Oncology (2023) Vol. 35, Iss. 2
Open Access | Times Cited: 7

The role of epigenetic modifications in Colorectal Cancer Metastasis
Riya Su, Xinlin Wu, Tao Liang, et al.
Clinical & Experimental Metastasis (2022) Vol. 39, Iss. 4, pp. 521-539
Open Access | Times Cited: 12

The Role of NAD+, SIRTs Interactions in Stimulating and Counteracting Carcinogenesis
Ekaterina Podyacheva, Yana Toropova
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7925-7925
Open Access | Times Cited: 5

Potential of histone deacetylase inhibitors for the therapy of ovarian cancer
Fengyi Guo, Hongjing Wang
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8

ADP-Ribosylation as Post-Translational Modification of Proteins: Use of Inhibitors in Cancer Control
Palmiro Poltronieri, Masanao Miwa, Mitsuko Masutani
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10829-10829
Open Access | Times Cited: 10

β-1,3-glucan from Euglena gracilis : a promising epidrug targeting epigenetic regulators PRMTs and SIRTs for therapeutic applications in ovarian cancer
Varsha Virendra Palol, Kamran Waidha, M. Balasubramanian, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-16
Closed Access

MiR-363 suppresses the tumor growth of natural killer/T-cell lymphoma via the SIRT6/PI3K/AKT axis
Bei Xu, Lian Jiang, Jiali Cui, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 23, pp. 1276-1276
Open Access | Times Cited: 2

Page 1

Scroll to top